Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.
about
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiologyIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesRole of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats17-Hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats.Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancyAltered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.Effects of hyperhomocysteinemia on arterial pressure and nitric oxide production in pregnant ratsRecombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.Preeclampsia and future cardiovascular risk: are women and general practitioners aware of this relationship? The experience from a portuguese centreRisk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.Effects of maternal serum on permeability of glomerular endothelial cell membrane.Syncytiotrophoblast derived extracellular vesicles transfer functional placental miRNAs to primary human endothelial cells.Advances in the pathophysiology of pre-eclampsia and related podocyte injury.The effect of resveratrol on blood pressure in a rat model of preeclampsia.Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndromeNormal pregnancy: mechanisms underlying the paradox of a ouabain-resistant state with elevated endogenous ouabain, suppressed arterial sodium calcium exchange, and low blood pressureRecent insights into the pathophysiology of preeclampsia.Endothelin-1 is not a Mechanism of IL-17 Induced Hypertension during Pregnancy.Brain cell apoptosis and enhancement of nervous excitability in pregnant rats with high plasma levels of homocysteineRole of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia.Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes.Alterations in maternal and fetal heart functions accompany failed spiral arterial remodeling in pregnant mice.Receptor-activating autoantibodies and disease: preeclampsia and beyond.Pregnancy-Associated Heart Failure: A Comparison of Clinical Presentation and Outcome between Hypertensive Heart Failure of Pregnancy and Idiopathic Peripartum CardiomyopathyThe Effect of High Dose Folic Acid throughout Pregnancy on Homocysteine (Hcy) Concentration and Pre-Eclampsia: A Randomized Clinical TrialHypertensive disorders of pregnancy: Case definitions & guidelines for data collection, analysis, and presentation of immunization safety data.Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP ratsAn increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia.Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia.The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy.Immune Mechanisms Linking Obesity and Preeclampsia.Differential expression of β-catenin and Dickkopf-1 in the third trimester placentas from normal and preeclamptic pregnancies: a comparative study.Abnormalities of Selected Trace Elements in Patients with Coronary Artery Disease.Matrix metalloproteinases as drug targets in preeclampsiaB Cell in Autoimmune Diseases.Endothelin, kidney disease, and hypertension.Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancyHypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.Exercise training attenuates placental ischemia-induced hypertension and angiogenic imbalance in the rat.
P2860
Q26865332-5477BDD6-0FC5-4867-8B86-57832E42BB3CQ28388335-5FB80A68-DCA1-4C41-B639-4F773CE56B02Q28571017-098B13B2-B0F7-416D-A6A0-3952AC96B095Q33607461-C9144166-CA38-4E7C-8001-074172D3E313Q33607465-EEA3BA1E-8D3A-4342-AF83-8F6E6FFCDE13Q33665037-28D473A8-2C75-4B07-AC45-1ED50318A025Q33666694-BE1E7246-E43C-4122-980F-20AA7790DA26Q33666742-6EB3AB7A-B475-4B48-A3A6-BFB42012C0B6Q33737470-69C89355-DBD8-4497-B951-51CFE3C55A0FQ33757451-D8D100F2-DCA6-4587-86F7-247B3E159A99Q33793455-EF03E306-6D19-41A2-B3C6-C09CC10B1417Q33825219-41E240D0-D0D6-4CC4-B4E3-F7D87E73BF20Q33870546-D5272DAA-6F07-4815-AA5E-156FD8A53CBFQ33983807-B31A231D-8B98-499A-B3EE-F27FFC59E72DQ33994926-42C44BD7-7F74-46CE-8880-6075B2ACFCB2Q34025660-3A3682C9-DF6E-430F-98AF-880223A42BCAQ34247076-1312AB7F-3CBB-413C-883A-22ABAA988F0AQ34404445-70117A31-BB75-4BDC-A792-4B631F0E5450Q34533218-A56DA48B-CEF8-4613-983F-1948C144C884Q34720155-333F3022-F199-4E4C-BF1C-451C91CED041Q34785813-966EF5EA-98F5-4A03-B24D-A567B8747101Q35029700-856A96E7-4E44-4A24-85B6-37320BE3D502Q35592481-7399316E-55D4-4E85-B7FD-BC1F36888FDDQ35707881-FCE30FD7-9FE0-4EEB-833C-17CE19719680Q35740097-B641BD41-314D-4EE7-AFA6-A5B8D056A9D3Q36014095-0821B408-8BD6-46D3-B2A7-E99BF9271E71Q36079659-C47AC82D-BFC5-4E23-853C-988D8BFB1046Q36339273-18CC6233-F59A-4A42-9F2F-D3D48A46B017Q36339336-5032B251-9668-48D2-A95F-526A5D1EB4C4Q36355165-B58BF114-FAFA-4D1E-970E-EAA0EFDAB7B4Q36407259-273C8A6A-5338-4C5D-81C2-E23028DD093AQ36409599-0A348AA8-121E-4465-9291-8B4492DF6F34Q36689664-70D47BF5-BB15-4860-8310-534258834322Q36721778-2EE518EB-80C9-4634-A389-B7B9CCD82FEAQ36910638-CA43967A-2CD9-4596-9E96-AE313C55B82CQ36954468-295A362A-640D-4BBC-B4ED-3A24DD2FDA2EQ37244292-8F8E6ACB-90CC-41D6-84AA-F81AE011F94CQ37353537-6E1138D3-A5F7-47BF-B9CA-A239D0E2D8F2Q37447371-9BA3FEB5-0D55-4648-879E-4649260D4098Q37540997-3310E189-671A-41CF-82C1-F99DCC4E22C5
P2860
Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent progress toward the und ...... ertension during preeclampsia.
@en
Recent progress toward the und ...... ertension during preeclampsia.
@nl
type
label
Recent progress toward the und ...... ertension during preeclampsia.
@en
Recent progress toward the und ...... ertension during preeclampsia.
@nl
prefLabel
Recent progress toward the und ...... ertension during preeclampsia.
@en
Recent progress toward the und ...... ertension during preeclampsia.
@nl
P2093
P2860
P921
P1433
P1476
Recent progress toward the und ...... ertension during preeclampsia.
@en
P2093
Babbette D LaMarca
Jeffery Gilbert
Joey P Granger
P2860
P304
P356
10.1161/HYPERTENSIONAHA.107.108837
P407
P577
2008-02-07T00:00:00Z